Catalent
CTLT
#1809
Rank
โ‚น1.061 T
Marketcap
โ‚น5,848
Share price
0.00%
Change (1 day)
20.03%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น583.12. In 2023 the company made an earnings per share (EPS) of -โ‚น626.42 a decrease over its 2022 EPS that were of โ‚น209.11.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-15.85%
2023-โ‚น626.42-399.56%
2022โ‚น209.11-30.58%
2021โ‚น301.2379.67%
2020โ‚น167.66114.12%
2019โ‚น78.30-15%
2018โ‚น92.1275.44%
2017โ‚น52.51-22.97%
2016โ‚น68.17-59.56%
2015โ‚น168.58282.05%
2014โ‚น44.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น30.40-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น549.04-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น69.09-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น136.34-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA